Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reumap: Open-label phase II study of bovine intestinal alkaline phosphatase in rheumatoid arthritis
2008-007346-63Phase 2Suspended
- Sponsor
- Alloksys Life Sciences
- Start
- Oct 2010
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bovine intestinal alkaline phosphatase in rheumatoid arthritis (RA), sponsored by Alloksys Life Sciences. Primary endpoint: Primary Outcome Measures (Days 1-8 Laboratory Phase). Started Oct 2010; status: suspended.
02
Drugs
bovine intestinal alkaline phosphatase
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2008-007346-63.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007346-63.